Berlin – 22 Apr 2015 – KCR, a Contract Research Organization operating in 19 countries in Europe as well as the U.S., has appointed Joette Keen as Head of Biometrics (BMX) and Clinical Trial Data Execution Systems.
In her new role Ms. Keen will be responsible for the implementation and delivery of KCR Data Management (DM) and statistics services. Moreover, she will oversee KCR’s computerized systems related to clinical data processing. These include Electronic Data Capture (EDC), Clinical Trial Management System (CTMS), as well as KCR’s electronic documentation management system.
Joette Keen brings to KCR more than 30 years of extensive experience in clinical data management, Data Management systems, as well as international operations management. Prior to joining KCR, Joette worked at Covance supporting all areas of global technical solutions in DM.
Prior to this role Ms. Keen spent 32 years at Merck and Co., where she held various positions in clinical DM. In one of her management roles at Merck, Ms. Keen assumed full responsibilities for process design, implementation as well as quality assurance and continuous improvement in clinical DM. Joette Keen represented the company in various FDA and other country-specific agency inspections. Ms. Keen was also an instrumental part of the implementation of the Continuous Data Flow initiative at Merck, which allowed to bring the time from Last Patient Last Visit (LPLV) to Database Lock Down (DBL) to 10 days.
“The future is not DM data, versus Interactive Web Response System (IWRS) data, versus another systems data. The future is to have an access to all data generated during the execution of trials to enable effective and scientifically based study management, as well as to ensure trial execution transparency across various departments and with our clients,” said Mike Jagielski, President & CEO of KCR. “Joette will be an extremely valuable part of the leadership team at KCR. She will be responsible for the successful delivery of our biometrics services as well as for management of trial execution data and systems across our service areas.” Ms. Keen will be located in Dallas, Texas, U.S.
KCR is a Contract Research Organization (CRO) operating across 19 countries in Europe as well as the U.S. The company is a strategic solutions provider for pharmaceutical and biotechnology firms who are looking for a reliable alternative to top tier CROs. Over 300 professionals offer full service capabilities in three main product lines: Trial Execution, Functional Service Provision (FSP) and Late Phase, across a wide range of therapeutic areas. Focusing on knowledge, quality and innovation, KCR and its services supports 12 of the Top 20 Global Pharma companies, as well as biotech firms from Europe, Israel and the U.S. on long standing contracts. For more information please visit: www.kcrcro.com.
KCR: We see human behind every number
Associate Director, PR & Marketing
mobile: (+48) 605 053 164